z-logo
open-access-imgOpen Access
Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells
Author(s) -
Yusuke Murase,
Kenji Hosoya,
Takachika Sato,
Sangho Kim,
Masahiro Okumura
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8272
Subject(s) - oncogene , discovery and development of mtor inhibitors , pi3k/akt/mtor pathway , cancer research , cell cycle , dual (grammatical number) , biology , molecular medicine , apoptosis , biochemistry , art , literature

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom